Rosemary Maxwell

Trump Administration Issues Executive Order To Lower Prescription Drug Costs

Preparing For A Regulatory Reset: How Republicans Could Leverage The Congressional Review Act In 2025

September 2024 Medicaid Rebate Final Rule: Key Issues For Manufacturers

Biden Administration Issues Rules Requiring Insurer Transparency On Drug Spending, Rebates And Fees: What Manufacturers Need To Know

Pharmacy Point-Of-Sale Price Concession And PBM Service Fee Safe Harbor Final Rule May Reshape Medicare Part D: What Pharmaceutical Manufacturers Need To Know Now

Post-Election Analysis 2020: Life Sciences & Healthcare

Navigating The Post-Election Landscape: Life Sciences & Healthcare

HHS Proposes New Protections For Value-Based Arrangements And Other Revisions To AKS Safe Harbors, CMP Exceptions And Stark Exceptions

HHS OIG's Proposed Rule: Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals

Impact Of The Mid-Term Elections On The Life Sciences Industry